Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

DOI Full Paper Access

587

Citations

22

References

2021

Year

James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Perić, Temur Margania, Hiroyuki Murai, Małgorzata Bilińska, R Shakarishvili, Marek Śmiłowski,

The Lancet Neurology

MedicineGeneralised Myasthenia Gravis

References

	Year	Citations

Page 1